PMC:7205724 / 514-738 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"17","span":{"begin":19,"end":22},"obj":"Gene"},{"id":"18","span":{"begin":78,"end":81},"obj":"Gene"},{"id":"19","span":{"begin":46,"end":54},"obj":"Species"},{"id":"21","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"53","span":{"begin":97,"end":114},"obj":"Species"},{"id":"54","span":{"begin":116,"end":125},"obj":"Species"},{"id":"55","span":{"begin":179,"end":185},"obj":"Species"},{"id":"65","span":{"begin":151,"end":164},"obj":"Disease"},{"id":"66","span":{"begin":166,"end":174},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Gene:3569"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Gene:3569"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:C000657245"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Tax:2697049"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"Tax:2697049"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"Tax:9606"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D034062"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T6","span":{"begin":116,"end":120},"obj":"Disease"},{"id":"T7","span":{"begin":166,"end":174},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":137,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":179,"end":185},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":157,"end":164},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T5","span":{"begin":60,"end":68},"obj":"Species"},{"id":"T6","span":{"begin":116,"end":125},"obj":"Species"},{"id":"T7","span":{"begin":166,"end":174},"obj":"Species"},{"id":"T8","span":{"begin":179,"end":185},"obj":"Species"}],"attributes":[{"id":"A5","pred":"ncbi_taxonomy_id","subj":"T5","obj":"NCBItxid:2697049"},{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"},{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:2697049"},{"id":"A8","pred":"ncbi_taxonomy_id","subj":"T8","obj":"NCBItxid:9605"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T10","span":{"begin":84,"end":92},"obj":"Sentence"},{"id":"T11","span":{"begin":93,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"17","span":{"begin":19,"end":22},"obj":"Gene"},{"id":"19","span":{"begin":46,"end":54},"obj":"Species"},{"id":"21","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"18","span":{"begin":78,"end":81},"obj":"Gene"},{"id":"53","span":{"begin":97,"end":114},"obj":"Species"},{"id":"54","span":{"begin":116,"end":125},"obj":"Species"},{"id":"65","span":{"begin":151,"end":164},"obj":"Disease"},{"id":"66","span":{"begin":166,"end":174},"obj":"Disease"},{"id":"55","span":{"begin":179,"end":185},"obj":"Species"}],"attributes":[{"id":"A66","pred":"pubann:denotes","subj":"66","obj":"MESH:C000657245"},{"id":"A17","pred":"pubann:denotes","subj":"17","obj":"Gene:3569"},{"id":"A54","pred":"pubann:denotes","subj":"54","obj":"Tax:2697049"},{"id":"A53","pred":"pubann:denotes","subj":"53","obj":"Tax:2697049"},{"id":"A19","pred":"pubann:denotes","subj":"19","obj":"Tax:9606"},{"id":"A65","pred":"pubann:denotes","subj":"65","obj":"MESH:D034062"},{"id":"A18","pred":"pubann:denotes","subj":"18","obj":"Gene:3569"},{"id":"A21","pred":"pubann:denotes","subj":"21","obj":"MESH:C000657245"},{"id":"A55","pred":"pubann:denotes","subj":"55","obj":"Tax:9606"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T45","span":{"begin":19,"end":22},"obj":"Protein"},{"id":"T89","span":{"begin":78,"end":81},"obj":"Protein"}],"attributes":[{"id":"A45","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A46","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A47","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A48","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A49","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A50","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A51","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A52","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A53","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A54","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A55","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A56","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A57","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A58","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A59","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A60","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A61","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A62","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A63","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A64","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A65","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A66","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A67","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A68","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A69","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A70","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A71","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A72","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A73","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A74","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A75","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A76","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A77","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A78","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A79","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A80","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A81","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A82","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A83","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A84","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A85","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A86","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A87","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A88","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A0S0B0"},{"id":"A89","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A90","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A91","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A92","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A93","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A94","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A95","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A96","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A97","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A98","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A99","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A100","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A101","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A102","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A103","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A104","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A105","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A106","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A107","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A108","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A109","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A110","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A111","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A112","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A113","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A114","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A115","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A116","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A117","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A118","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A119","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A120","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A121","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A122","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A123","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A124","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A125","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A126","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A127","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A128","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A129","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A130","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A131","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A132","pred":"uniprot_id","subj":"T89","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T77","span":{"begin":9,"end":10},"obj":"-COMMA-"},{"id":"T78","span":{"begin":11,"end":13},"obj":"DT"},{"id":"T79","span":{"begin":14,"end":22},"obj":"NN"},{"id":"T80","span":{"begin":22,"end":23},"obj":"-COMMA-"},{"id":"T81","span":{"begin":24,"end":27},"obj":"MD"},{"id":"T82","span":{"begin":28,"end":34},"obj":"VB"},{"id":"T83","span":{"begin":35,"end":42},"obj":"NN"},{"id":"T84","span":{"begin":43,"end":45},"obj":"IN"},{"id":"T85","span":{"begin":46,"end":54},"obj":"NNS"},{"id":"T86","span":{"begin":55,"end":59},"obj":"IN"},{"id":"T87","span":{"begin":60,"end":68},"obj":"NN"},{"id":"T88","span":{"begin":69,"end":72},"obj":"CC"},{"id":"T89","span":{"begin":73,"end":77},"obj":"JJ"},{"id":"T90","span":{"begin":78,"end":81},"obj":"NN"},{"id":"T91","span":{"begin":84,"end":92},"obj":"NN"},{"id":"T92","span":{"begin":93,"end":96},"obj":"DT"},{"id":"T93","span":{"begin":97,"end":102},"obj":"JJ"},{"id":"T94","span":{"begin":103,"end":114},"obj":"NN"},{"id":"T95","span":{"begin":114,"end":115},"obj":"-COMMA-"},{"id":"T96","span":{"begin":116,"end":125},"obj":"NN"},{"id":"T97","span":{"begin":125,"end":126},"obj":"-COMMA-"},{"id":"T98","span":{"begin":127,"end":130},"obj":"MD"},{"id":"T99","span":{"begin":131,"end":136},"obj":"VB"},{"id":"T100","span":{"begin":137,"end":138},"obj":"DT"},{"id":"T101","span":{"begin":139,"end":150},"obj":"RB"},{"id":"T102","span":{"begin":151,"end":156},"obj":"JJ"},{"id":"T103","span":{"begin":157,"end":164},"obj":"NN"},{"id":"T104","span":{"begin":164,"end":165},"obj":"-COMMA-"},{"id":"T105","span":{"begin":166,"end":174},"obj":"NN"},{"id":"T106","span":{"begin":174,"end":175},"obj":"-COMMA-"},{"id":"T107","span":{"begin":176,"end":178},"obj":"IN"},{"id":"T108","span":{"begin":179,"end":185},"obj":"NNS"},{"id":"T109","span":{"begin":187,"end":191},"obj":"RB"},{"id":"T110","span":{"begin":191,"end":192},"obj":"-COMMA-"},{"id":"T111","span":{"begin":193,"end":195},"obj":"PRP"},{"id":"T112","span":{"begin":196,"end":200},"obj":"MD"},{"id":"T113","span":{"begin":201,"end":208},"obj":"VB"},{"id":"T114","span":{"begin":209,"end":211},"obj":"DT"},{"id":"T115","span":{"begin":212,"end":220},"obj":"NN"},{"id":"T116","span":{"begin":221,"end":223},"obj":"IN"}],"relations":[{"id":"R71","pred":"arg2Of","subj":"T79","obj":"T77"},{"id":"R72","pred":"arg1Of","subj":"T79","obj":"T78"},{"id":"R73","pred":"arg1Of","subj":"T82","obj":"T80"},{"id":"R75","pred":"arg2Of","subj":"T82","obj":"T81"},{"id":"R77","pred":"arg2Of","subj":"T83","obj":"T82"},{"id":"R78","pred":"arg1Of","subj":"T82","obj":"T84"},{"id":"R79","pred":"arg2Of","subj":"T85","obj":"T84"},{"id":"R80","pred":"arg1Of","subj":"T85","obj":"T86"},{"id":"R81","pred":"arg2Of","subj":"T88","obj":"T86"},{"id":"R82","pred":"arg1Of","subj":"T87","obj":"T88"},{"id":"R83","pred":"arg2Of","subj":"T90","obj":"T88"},{"id":"R84","pred":"arg1Of","subj":"T90","obj":"T89"},{"id":"R85","pred":"arg1Of","subj":"T94","obj":"T92"},{"id":"R86","pred":"arg1Of","subj":"T94","obj":"T93"},{"id":"R87","pred":"arg1Of","subj":"T94","obj":"T95"},{"id":"R88","pred":"arg2Of","subj":"T96","obj":"T95"},{"id":"R89","pred":"arg1Of","subj":"T99","obj":"T97"},{"id":"R90","pred":"arg1Of","subj":"T94","obj":"T98"},{"id":"R91","pred":"arg2Of","subj":"T99","obj":"T98"},{"id":"R92","pred":"arg1Of","subj":"T94","obj":"T99"},{"id":"R93","pred":"arg2Of","subj":"T103","obj":"T99"},{"id":"R94","pred":"arg1Of","subj":"T103","obj":"T100"},{"id":"R95","pred":"arg1Of","subj":"T102","obj":"T101"},{"id":"R96","pred":"arg1Of","subj":"T103","obj":"T102"},{"id":"R97","pred":"arg1Of","subj":"T103","obj":"T104"},{"id":"R98","pred":"arg2Of","subj":"T105","obj":"T104"},{"id":"R99","pred":"arg1Of","subj":"T99","obj":"T106"},{"id":"R100","pred":"arg1Of","subj":"T99","obj":"T107"},{"id":"R101","pred":"arg2Of","subj":"T108","obj":"T107"},{"id":"R102","pred":"arg1Of","subj":"T113","obj":"T109"},{"id":"R103","pred":"arg1Of","subj":"T113","obj":"T110"},{"id":"R104","pred":"arg1Of","subj":"T111","obj":"T112"},{"id":"R105","pred":"arg2Of","subj":"T113","obj":"T112"},{"id":"R106","pred":"arg1Of","subj":"T111","obj":"T113"},{"id":"R107","pred":"arg2Of","subj":"T115","obj":"T113"},{"id":"R108","pred":"arg1Of","subj":"T115","obj":"T114"},{"id":"R109","pred":"arg1Of","subj":"T115","obj":"T116"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T5","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T6","span":{"begin":116,"end":125},"obj":"Disease"},{"id":"T7","span":{"begin":166,"end":174},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":84,"end":92},"obj":"Sentence"},{"id":"T11","span":{"begin":93,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"cilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.\n\nAbstract\nThe novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of "}